GILEAD SCIENCES, INC. — Director's Dealing 2015

Sep 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-09-15

Reporting Person: BISCHOFBERGER NORBERT W (EVP, R&D and CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-15	Common Stock	M	70000	$23.60	Acquired	235168	Direct
2015-09-15	Common Stock	S	17045	$109.5968	Disposed	218123	Direct
2015-09-15	Common Stock	S	41153	$110.9154	Disposed	176970	Direct
2015-09-15	Common Stock	S	11802	$111.5587	Disposed	165168	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-15	Non-Qualified Stock Option (right to buy)	$23.60	M	70000	Disposed	2019-01-21	Common Stock (70000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $109.06 to $110.03. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $110.40 to $111.3910. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request

F5: Sale prices reported for the transactions reported here range from $111.40 to $111.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.